Business
AdaptHealth Corp. Announces First Quarter 2025 Results
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)-- AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered,
About this update from Adapthealth Corp.
[{"type":"text","content":" CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--\nAdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2025.\n\nFirst Quarter Results and Highlights\n\nAll comparisons are to the quarter ended March 31, 2024.\n\n\nNet revenue was $777.9 million compared to $792.5 million, a decrease of 1.8%.\n\n\nNet loss attributable to AdaptHealth Corp. was $7.2 million compared to net loss of $2.1 million.\n\n\nAdjusted EBITDA was $127.9 million compared to $158.5 million, a decrease of 19.3%.\n\n\nCash flow from operations was $95.5 million, an increase from $49.0 million, and free cash flow was negative $0.1 million, compared to negative $38.9 million.\n\n\nSubsequent to March 31, 2025, the Company closed on its previously disclosed agreement to sell certain incontinence assets in its Wellness at Home segment to a third party, and also signed a definitive agreement to sell certain infusion assets in its Wellness at Home segment to a third party, which is expected to close in the second quarter of 2025.\n\nManagement Commentary\n\n“Amid elevated uncertainty in the external environment, we at AdaptHealth have stayed the course, with a relentless focus on improving our business and providing exceptional service to the 4.2 million patients that depend on us,” said Suzanne Foster, Chief Executive Officer of AdaptHealth. \"Reflecting that focus, we delivered another quarter of solid results, we continued to make progress on our financial position with additional debt reduction, and for a second consecutive quarter, our Diabetes Health segment continued to show signs of improvement. I am excited by the tremendous opportunity ahead, as we continue to leverage our geographic reach, operational scale and patient service excellence to capture market share and drive consistent and sustainable organic growth in each of our four segments.”\n\nFinancial Outlook\n\nThe Company is updating previous financial guidance for fiscal year 2025 to account for the disposition of certain incontinence assets, as follows:\n\n\nNet revenue of $3.18 billion to $3.32 billion, from $3.22 billion to $3.36 billion\n\n\nAdjusted EBITDA of $665 million ...